Affiliation:
1. State Key Laboratory of Tree Genetics and Breeding, Key Laboratory of Tree Breeding and Cultivation of State Forestry Administration, The Research Institute of Forestry, Chinese Academy of Forestry, Beijing,China
2. CSIRO Agriculture and Food, Canberra, ACT,Australia
Abstract
Background:
Taxus is a valuable woody species with important medicinal value. The bark
of Taxus can produce taxol, a natural antineoplastic drug that is widely used in the treatment of breast,
ovarian and lung cancers. However, the low content of taxol in the bark of Taxus can not meet the
growing clinical demands, so the current research aims at finding ways to increase taxol production.
Objective:
In this review, the research progress of taxol including the factors affecting the taxol content,
biosynthesis pathway of taxol, production of taxol in vitro and the application of multi-omics approaches
in Taxus as well as future research prospects will be discussed.
Results:
The taxol content is not only dependent on the species, age and tissues but is also affected by
light, moisture levels, temperature, soil fertility and microbes. Most of the enzymes in the taxol biosynthesis
pathway have been identified and characterized. Total chemical synthesis, semi-synthesis, plant
cell culture and biosynthesis in endophytic fungi have been explored to product taxol. Multi-omics
have been used to study Taxus and taxol.
Conclusion:
Further efforts in the identification of unknown enzymes in the taxol biosynthesis pathway,
establishment of the genetic transformation system in Taxus and the regulatory mechanism of
taxol biosynthesis and Taxus cell growth will play a significant role in improving the yield of taxol in
Taxus cells and plants.
Funder
Natural Science Foundation of China
Publisher
Bentham Science Publishers Ltd.
Subject
Pharmaceutical Science,Biotechnology
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献